CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: pyrrolopyrazine
Accession: CHEBI:48337
browse the term
Synonyms: related_synonym: pyrrolopyrazines
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
maculosin inhibits the reaction [Diethylnitrosamine results in decreased expression of BAX protein]
CTD
PMID:34726822
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
ISO
maculosin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein]
CTD
PMID:34726822
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
multiple interactions
ISO
maculosin inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 mRNA]; maculosin inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 protein]
CTD
PMID:34726822
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
multiple interactions
ISO
maculosin inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]
CTD
PMID:34726822
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Gsr
glutathione-disulfide reductase
multiple interactions
ISO
maculosin inhibits the reaction [Diethylnitrosamine results in decreased activity of GSR protein]
CTD
PMID:34726822
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
multiple interactions
ISO
maculosin inhibits the reaction [Diethylnitrosamine results in increased expression of PIK3R1 protein modified form]
CTD
PMID:34726822
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Pten
phosphatase and tensin homolog
multiple interactions
ISO
maculosin inhibits the reaction [Diethylnitrosamine results in decreased expression of PTEN protein]
CTD
PMID:34726822
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Tp53
tumor protein p53
multiple interactions
ISO
maculosin inhibits the reaction [Diethylnitrosamine results in decreased expression of TRP53 mRNA]; maculosin inhibits the reaction [Diethylnitrosamine results in decreased expression of TRP53 protein]
CTD
PMID:34726822
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
increases metabolic processing
ISO
CYP2C8 protein results in increased metabolism of zopiclone
CTD
PMID:12464242
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19880
chemical entity
19878
atom
19878
nonmetal atom
19800
nitrogen atom
18979
nitrogen molecular entity
18979
organonitrogen compound
18833
organonitrogen heterocyclic compound
18153
pyrrolopyrazine
9
(6S,8aS)-2-(benzylsulfonyl)-N-\{[1-(N'-hydroxycarbamimidoyl)piperidin-4-yl]methyl\}-4-oxooctahydropyrrolo[1,2-a]pyrazine-6-carboxamide
0
(8aS)-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione
0
(S)-3-(indol-3-ylmethyl)-6,7,8,8a-tetrahydropyrrolo[1,2-a]pyrazin-1-one
0
(S)-3-\{[2-(1,1-dimethylallyl)-indol-3-yl]methyl\}-6,7,8,8a-tetrahydropyrrolo[1,2-a]pyrazin-1-one
0
1,2,3,4-tetrahydro-2-methyl-3-methylene-1,4-dioxopyrazino[1,2-a]indole
0
1,3-Dimethylpyrrolo[1,2-a]pyrazine
0
1,4-Dimethylpyrrolo[1,2-a]pyrazine
0
1-Methylpyrrolo[1,2-a]pyrazine
0
1-hydroxy-3-(indol-3-ylmethyl)-6H,7H,8H-5lambda(5)-pyrrolo[1,2-a]pyrazin-5-ylium
0
1-hydroxy-3-\{[2-(1,1-dimethylallyl)-indol-3-yl]methyl\}-4H,6H,7H,8H-pyrrolo[1,2-a]pyrazin-2-ium
0
1-hydroxy-3-\{[2-(1,1-dimethylallyl)-indol-3-yl]methyl\}-6H,7H,8H-5lambda(5)-pyrrolo[1,2-a]pyrazin-5-ylium
0
18-oxotryprostatin A
0
2-\{3-[(3S,8aS)-1,4-dioxooctahydropyrrolo[1,2-a]pyrazin-3-yl]propyl\}guanidine
0
3,4-Dimethylpyrrolo[1,2-a]pyrazine
0
3-methylpyrrolo[1,2-a]pyrazine
0
4-(7-butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)phenol
0
4-Methylpyrrolo[1,2-a]pyrazine
0
6-hydroxydeoxybrevianamide E
0
6-hydroxytryprostatin B
0
7-Azaindolizine
0
Brevianamide K
0
Brevianamide S
0
Brevianamide T
0
Le-pyrrolopyrazine A
0
Le-pyrrolopyrazine B
0
Le-pyrrolopyrazine C
0
Nannozinone A
0
Nannozinone B
0
Pyrocoll
0
Sorazinone A
0
brevianamide F +
0
butyl (2S,3S)-3-(trans-4-aminocyclohexyl)-3-(\{[2-(benzylsulfonyl)-4-oxo-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-6-yl]carbonyl\}amino)-2-hydroxypropanoate
0
cordysinin A
0
cyclo(L-His-L-Pro)
0
cyclo(L-Leu-L-Pro)
0
cyclo(L-arginyl-L-prolyl)(+1)
0
cyclo(Pro-Arg)
0
deoxybrevianamide E
0
maculosin
8
notoamide C
0
notoamide E
0
notoamide S +
0
peramine
0
tryprostatin A
0
tryprostatin B
0
zopiclone +
1
Path 2
CHEBI ontology
19880
subatomic particle
19878
composite particle
19878
hadron
19878
baryon
19878
nucleon
19878
atomic nucleus
19878
atom
19878
main group element atom
19817
p-block element atom
19817
p-block molecular entity
19817
carbon group molecular entity
19757
organic molecular entity
19754
organic molecule
19706
organic cyclic compound
19495
organic heterocyclic compound
18874
organic heteropolycyclic compound
18300
organic heterobicyclic compound
17242
pyrrolopyrazine
9
(6S,8aS)-2-(benzylsulfonyl)-N-\{[1-(N'-hydroxycarbamimidoyl)piperidin-4-yl]methyl\}-4-oxooctahydropyrrolo[1,2-a]pyrazine-6-carboxamide
0
(8aS)-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione
0
(S)-3-(indol-3-ylmethyl)-6,7,8,8a-tetrahydropyrrolo[1,2-a]pyrazin-1-one
0
(S)-3-\{[2-(1,1-dimethylallyl)-indol-3-yl]methyl\}-6,7,8,8a-tetrahydropyrrolo[1,2-a]pyrazin-1-one
0
1,2,3,4-tetrahydro-2-methyl-3-methylene-1,4-dioxopyrazino[1,2-a]indole
0
1,3-Dimethylpyrrolo[1,2-a]pyrazine
0
1,4-Dimethylpyrrolo[1,2-a]pyrazine
0
1-Methylpyrrolo[1,2-a]pyrazine
0
1-hydroxy-3-(indol-3-ylmethyl)-6H,7H,8H-5lambda(5)-pyrrolo[1,2-a]pyrazin-5-ylium
0
1-hydroxy-3-\{[2-(1,1-dimethylallyl)-indol-3-yl]methyl\}-4H,6H,7H,8H-pyrrolo[1,2-a]pyrazin-2-ium
0
1-hydroxy-3-\{[2-(1,1-dimethylallyl)-indol-3-yl]methyl\}-6H,7H,8H-5lambda(5)-pyrrolo[1,2-a]pyrazin-5-ylium
0
18-oxotryprostatin A
0
2-\{3-[(3S,8aS)-1,4-dioxooctahydropyrrolo[1,2-a]pyrazin-3-yl]propyl\}guanidine
0
3,4-Dimethylpyrrolo[1,2-a]pyrazine
0
3-methylpyrrolo[1,2-a]pyrazine
0
4-(7-butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)phenol
0
4-Methylpyrrolo[1,2-a]pyrazine
0
6-hydroxydeoxybrevianamide E
0
6-hydroxytryprostatin B
0
7-Azaindolizine
0
Brevianamide K
0
Brevianamide S
0
Brevianamide T
0
Le-pyrrolopyrazine A
0
Le-pyrrolopyrazine B
0
Le-pyrrolopyrazine C
0
Nannozinone A
0
Nannozinone B
0
Pyrocoll
0
Sorazinone A
0
brevianamide F +
0
butyl (2S,3S)-3-(trans-4-aminocyclohexyl)-3-(\{[2-(benzylsulfonyl)-4-oxo-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-6-yl]carbonyl\}amino)-2-hydroxypropanoate
0
cordysinin A
0
cyclo(L-His-L-Pro)
0
cyclo(L-Leu-L-Pro)
0
cyclo(L-arginyl-L-prolyl)(+1)
0
cyclo(Pro-Arg)
0
deoxybrevianamide E
0
maculosin
8
notoamide C
0
notoamide E
0
notoamide S +
0
peramine
0
tryprostatin A
0
tryprostatin B
0
zopiclone +
1